Alexion Pharmaceuticals files $250 million shelf

By Ted A. Knutson

Washington, Sept. 2 - Alexion Pharmaceuticals Inc. filed a $250 million shelf registration with the Securities and Exchange Commission.

The S-3 filing allows the company to issue common and preferred stock, warrants and debt securities. Securities may be issued in the form of convertibles.

The Cheshire, Conn.-based drug maker said offerings authorized by the shelf would be used for general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.